- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
What Went Wrong with Targeted Therapies, Gene Sequencing and Personalised Therapy in Newly Diagnosed vs. Recurrent Gliomas?
By
Yale Cancer Center
FEATURING
Antonio Omuro
By
Yale Cancer Center
FEATURING
Antonio Omuro
64 views
September 24, 2019
Comments 0
Login to view comments.
Click here to Login
Brain